Risk of hematologic malignancies in psoriasis and rheumatoid arthritis patients using long term TNF-α inhibitors: a retrospective nationwide study
Abstract This retrospective cohort study included all user of tumor necrosis factor-α inhibitors (TNFi), including etanercept, infliximab, adalimumab, and golimumab, among Korean patients with psoriasis and rheumatoid arthritis (N of user = 7,645) and the non-user who was diagnosed with same disease...
Saved in:
| Main Authors: | Jihun Song, Seong Rae Kim, Yu-Jin Kim, Sun Jae Park, Seogsong Jeong, Sang Min Park |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-03-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-90996-z |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Influence of TNF-alpha on the efficacy of anemia correction in patients with lymphoproliferative disorders
by: N. A. Romanenko, et al.
Published: (2022-11-01) -
Tuberculosis screening in pediatric patients receiving TNF-alpha inhibitor therapy
by: Manolya Acar, et al.
Published: (2017-10-01) -
Chemotherapy of hematological malignancies in patients with COVID-19
by: T. S. Chudnova, et al.
Published: (2022-04-01) -
The LILRB family in hematologic malignancies: prognostic associations, mechanistic considerations, and therapeutic implications
by: Alan Hodges, et al.
Published: (2024-12-01) -
Clinical advances in antibody-drug conjugates for hematological malignancies
by: TANG Sijie, et al.
Published: (2024-12-01)